Randomized placebo controlled phase I/II trial of α-galactosylceramide for the treatment of chronic hepatitis C
Authors:
- Bart J. VeldtBVBart J. Veldt
- Hans J.J. van der VlietHVHans J.J. van der Vliet
- B. Mary E. von BlombergBBB. Mary E. von Blomberg
- Hans van VlierbergheHVHans van Vlierberghe
- Guido GerkenGGGuido Gerken
- Nobusuke NishiNNNobusuke Nishi
- Kunihiko HayashiKHKunihiko Hayashi
- Rik J. ScheperRSRik J. Scheper
- Robert J. de KnegtRKRobert J. de Knegt
- Alfons J.M. van Den EertweghAEAlfons J.M. van Den Eertwegh
- Harry L.A. JanssenHJHarry L.A. Janssen
- Carin M.J. van NieuwkerkCNCarin M.J. van Nieuwkerk
- 1 September 2007
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 47 (3) , 356-365
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Mechanism of action of interferon and ribavirin in treatment of hepatitis CNature, 2005
- Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patientsJournal of Experimental Medicine, 2005
- Circulating Vα24+Vβ11+ NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patientsClinical Immunology, 2005
- The immunoregulatory role of CD1d-restricted natural killer T cells in diseaseClinical Immunology, 2004
- Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunityBlood, 2004
- Activation of Natural Killer (NK) T Cells during Murine Cytomegalovirus Infection Enhances the Antiviral Response Mediated by NK CellsJournal of Virology, 2003
- Vα24-JαQ-Independent, CD1d-Restricted Recognition of α-Galactosylceramide by Human CD4+ and CD8αβ+ T LymphocytesThe Journal of Immunology, 2002
- NK T Cells Contribute to Expansion of CD8+T Cells and Amplification of Antiviral Immune Responses to Respiratory Syncytial VirusJournal of Virology, 2002
- Natural Killer T Cell Activation Inhibits Hepatitis B Virus Replication in VivoJournal of Experimental Medicine, 2000
- CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by GlycosylceramidesScience, 1997